Contact Us

Our Experience

Getting affordable medicines to your patients.

Fresenius Kabi’s experience plays a significant role in why we are BioSpecialized™. The sum of our oncology and immunology experience, our history demonstrates how we have focused this expertise on biosimilar therapies.

Our presence in the U.S. continues to grow. We have invested nearly $1 billion over the past few years1 in pharmaceutical manufacturing facilities in Illinois, New York and North Carolina, and in new distribution centers throughout the U.S. We delivered more than 700 million units of injectable medicine to the U.S. in 20211 and have secured additional capacity in different geographic areas to support product availability and rapid scalability to meet market needs. We continue our commitment to making affordable, high-quality health care available to more patients coping with critical and chronic diseases.

Wilson, NC

Melrose Park, IL

Grand Island, NY

Manufacturing and supply network
Why and how we aim to make medicines available to everyone. Read More

Oncology experience
Discover a rich portfolio developed over a quarter of a century. Read More

Immunology expertise
Learn about our long-term commitment to auto-immune therapies. Read More

Our biosimilars pipeline
What you can expect from us in the future. Read More

1. 2021 Data on file
Advanced science, manufacturing and support for biosimilars